Development of a brain-penetrant G9a methylase inhibitor to target Alzheimer’s disease-associated proteopathology

Journal:

Nature Communications

Published:

2025-05-07

DOI:

10.1038/s41467-025-59128-z

Affiliations:

8

Authors:

25

Go to article

Institutions	Authors	Share
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)	14.500000 14.500000	0.58
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA)	5.000000	0.20
University of Pennsylvania (Penn), United States of America (USA)	3.000000	0.12
Emory University, United States of America (USA)	2.000000	0.08
UNC Lineberger Comprehensive Cancer Center, United States of America (USA)	0.500000	0.02

Interested in Neurosciences?